FDA Says Philips Respironics Recalls Some Trilogy Ventilators(1)

May 13, 2024, 3:14 PM UTC

(Updates to add link in 6th bullet to previous story on Philips.)

  • The US Food and Drug Administration says Philips Respironics is recalling some of its Trilogy EVO continuous ventilators due to a software-related possible power malfunction.
  • The product names are Trilogy EVO, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal
  • The products were distributed from March 20, 2019 to February 16, 2024
  • Devices recalled in the US total 90,905
  • Philips Respironics is providing a software update for its Trilogy Evo continuous ventilators to rectify the problem
  • NOTE: From April 2024, Philips Warns of Faulty Ventilators Amid Mounting Safety ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.